Blood thinner pills vs warfarin after heart surgery

This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.

This trial compares two types of blood thinners (DOACs like apixaban or rivaroxaban, and warfarin) to see which works better for people who have a stroke while taking a DOAC. The goal is to find the safest and most effective option to prevent another stroke.

This trial tests whether it is safe for patients with atrial fibrillation to stop taking blood thinners after they have had heart surgery, including closure of the left atrial appendage. The goal is to see if these patients can avoid long-term medication without increasing the risk of stroke.

This study compares two blood thinners, apixaban (Eliquis) and warfarin, for people with atrial fibrillation who have just had heart valve surgery (repair or biological replacement). The goal is to see which medicine works better at preventing strokes and blood clots in the first three months after surgery.

This study compares a blood thinner pill (a factor Xa inhibitor) with warfarin (vitamin K antagonist) in people who have had a mechanical aortic valve replacement. It looks at which option works better and is safer over the long term.

This trial studies which blood-thinning medicine combination is safest and most helpful after coronary bypass surgery combined with a procedure to unblock the artery (endarterectomy). It focuses on preventing dangerous blood clots while also avoiding excess bleeding.